Bridgeway Capital Management’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-272,900
| Closed | -$84.5K | – | 1195 |
|
2025
Q1 | $84.5K | Hold |
272,900
| – | – | ﹤0.01% | 1068 |
|
2024
Q4 | $205K | Hold |
272,900
| – | – | ﹤0.01% | 1004 |
|
2024
Q3 | $341K | Hold |
272,900
| – | – | 0.01% | 948 |
|
2024
Q2 | $341K | Hold |
272,900
| – | – | 0.01% | 942 |
|
2024
Q1 | $306K | Hold |
272,900
| – | – | 0.01% | 1035 |
|
2023
Q4 | $363K | Hold |
272,900
| – | – | 0.01% | 1019 |
|
2023
Q3 | $289K | Hold |
272,900
| – | – | 0.01% | 1018 |
|
2023
Q2 | $303K | Sell |
272,900
-73,000
| -21% | -$81K | 0.01% | 1042 |
|
2023
Q1 | $512K | Sell |
345,900
-92,500
| -21% | -$137K | 0.01% | 882 |
|
2022
Q4 | $1.1M | Hold |
438,400
| – | – | 0.03% | 714 |
|
2022
Q3 | $1.41M | Buy |
438,400
+46,500
| +12% | +$149K | 0.04% | 653 |
|
2022
Q2 | $2.2M | Buy |
391,900
+110,100
| +39% | +$618K | 0.05% | 506 |
|
2022
Q1 | $1.74M | Buy |
+281,800
| New | +$1.74M | 0.03% | 636 |
|